These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24062393)

  • 41. The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG).
    Betts DR; Ammann RA; Hirt A; Hengartner H; Beck-Popovic M; Kuhne T; Nobile L; Caflisch U; Wacker P; Niggli FK
    Eur J Haematol; 2007 Jun; 78(6):468-76. PubMed ID: 17419750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.
    Harrison CJ; Hills RK; Moorman AV; Grimwade DJ; Hann I; Webb DK; Wheatley K; de Graaf SS; van den Berg E; Burnett AK; Gibson BE
    J Clin Oncol; 2010 Jun; 28(16):2674-81. PubMed ID: 20439644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monosomal karyotype in acute myeloid leukemia defines a distinct subgroup within the adverse cytogenetic risk category.
    Voutiadou G; Papaioannou G; Gaitatzi M; Lalayanni C; Syrigou A; Vadikoliou C; Saloum R; Anagnostopoulos A; Athanasiadou A
    Cancer Genet; 2013; 206(1-2):32-6. PubMed ID: 23246518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Karyotype complexity and prognosis in acute myeloid leukemia.
    Stölzel F; Mohr B; Kramer M; Oelschlägel U; Bochtler T; Berdel WE; Kaufmann M; Baldus CD; Schäfer-Eckart K; Stuhlmann R; Einsele H; Krause SW; Serve H; Hänel M; Herbst R; Neubauer A; Sohlbach K; Mayer J; Middeke JM; Platzbecker U; Schaich M; Krämer A; Röllig C; Schetelig J; Bornhäuser M; Ehninger G
    Blood Cancer J; 2016 Jan; 6(1):e386. PubMed ID: 26771812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia.
    Lazarevic V; Rosso A; Juliusson G; Antunovic P; Rangert-Derolf Å; Lehmann S; Möllgård L; Uggla B; Wennström L; Wahlin A; Höglund M; Johansson B
    Am J Hematol; 2015 Sep; 90(9):800-5. PubMed ID: 26088289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia.
    Silkjaer T; Nyvold CG; Juhl-Christensen C; Hokland P; Nørgaard JM
    Eur J Haematol; 2013 Oct; 91(4):295-303. PubMed ID: 23826975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of Chromosomal Abnormalities Commonly Observed in Adult Acute Myeloid Leukemia in Pakistan as Predictors of Prognosis.
    Shaikh MS; Ahmed ZA; Shaikh MU; Adil SN; Khurshid M; Moatter T; Rashid A; Karim F; Raheem A; Ali N
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1903-1906. PubMed ID: 30049204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.
    Bochtler T; Fröhling S; Krämer A
    Leukemia; 2015 Jun; 29(6):1243-52. PubMed ID: 25673237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML).
    Weh HJ; Kuse R; Hoffmann R; Seeger D; Suciu S; Kabisch H; Ritter J; Hossfeld DK
    Blut; 1988 Jan; 56(1):19-26. PubMed ID: 3422167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study.
    Klein K; Beverloo HB; Zimmermann M; Raimondi SC; von Neuhoff C; de Haas V; van Weelderen R; Cloos J; Abrahamsson J; Bertrand Y; Dworzak M; Fynn A; Gibson B; Ha SY; Harrison CJ; Hasle H; Elitzur S; Leverger G; Maschan A; Razzouk B; Reinhardt D; Rizzari C; Smisek P; Creutzig U; Kaspers GJL
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29341. PubMed ID: 34532968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Complex karyotype abnormalities in pediatric acute myeloid leukemia].
    Fleĭshman EV; Sokova OI; Kirichenko OP; Konstantinova LN; Metel'kova NF; Popa AV; Shneĭder MM
    Vestn Ross Akad Med Nauk; 2008; (5):3-7. PubMed ID: 18589906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia.
    Gmidène A; Sennana H; Wahchi I; Youssef YB; Jeddi R; Elloumi M; Saad A
    Hematology; 2012 Jan; 17(1):9-14. PubMed ID: 22549442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.
    van der Holt B; Breems DA; Berna Beverloo H; van den Berg E; Burnett AK; Sonneveld P; Löwenberg B
    Br J Haematol; 2007 Jan; 136(1):96-105. PubMed ID: 17129222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unfavorable, complex, and monosomal karyotypes: the most challenging forms of acute myeloid leukemia.
    Orozco JJ; Appelbaum FR
    Oncology (Williston Park); 2012 Aug; 26(8):706-12. PubMed ID: 22957403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of acute myeloid leukemia in elderly patients.
    Hiddemann W; Kern W; Schoch C; Fonatsch C; Heinecke A; Wörmann B; Büchner T
    J Clin Oncol; 1999 Nov; 17(11):3569-76. PubMed ID: 10550156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytogenetic survey of 80 patients with acute nonlymphocytic leukemia.
    Palka G; Calabrese G; Fioritoni G; Stuppia L; Guanciali Franchi P; Marino M; Antonucci A; Spadano A; Torlontano G
    Cancer Genet Cytogenet; 1992 Mar; 59(1):45-50. PubMed ID: 1555190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cytogenetic changes and their prognostic significance in elderly acute myeloid leukemia].
    Haus O; Kotlarek-Haus S; Duszeńko E; Makowska I; Potoczek S; Nowak E; Jaźwiec B; Kuliczkowski K
    Pol Arch Med Wewn; 2003 Jun; 109(6):571-7. PubMed ID: 14567089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.
    Strickland SA; Sun Z; Ketterling RP; Cherry AM; Cripe LD; Dewald G; Fernandez HF; Hicks GA; Higgins RR; Lazarus HM; Litzow MR; Luger SM; Paietta EM; Rowe JM; Vance GH; Wiernik P; Wiktor AE; Zhang Y; Tallman MS;
    Leuk Res; 2017 Aug; 59():55-64. PubMed ID: 28551161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular cytogenetic analysis of dicentric chromosomes in acute myeloid leukemia.
    Sarova I; Brezinova J; Zemanova Z; Ransdorfova S; Izakova S; Svobodova K; Pavlistova L; Berkova A; Cermak J; Jonasova A; Siskova M; Michalova K
    Leuk Res; 2016 Apr; 43():51-7. PubMed ID: 26821593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDS.
    Ganster C; Shirneshan K; Salinas-Riester G; Braulke F; Schanz J; Platzbecker U; Haase D
    Leuk Res; 2015 Oct; 39(10):1079-87. PubMed ID: 26278198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.